Clinical trial
Treatment of Moderate Vein Graft Lesions With Paclitaxel Drug Eluting Stents…
NCT00289835 · Laval University, Other · Completed
Key facts
| NCT number | NCT00289835 |
|---|---|
| Title | Treatment of Moderate Vein Graft Lesions With Paclitaxel Drug Eluting Stents: The VELETI Trial |
| Official title | Sealing Moderate Coronary Saphenous VEin Graft LEsions With the Paclitaxel-eluting Stent (Taxus) as a New Approach to Maintain Vein Graft Patency and Reduce Cardiac Events: a Pilot Intravascular Ultrasound Study. |
| Acronym | VELETI |
| Lead sponsor | Laval University, Other |
| Collaborators | Boston Scientific Corporation Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Coronary Artery Bypass Grafting |
| Intervention type | Device |
| Interventions | Paclitaxel eluting stent |
| Enrollment | 57 |
| Start date | Feb 1, 2006 |
| Primary completion | Oct 1, 2008 |
| Completion | Oct 1, 2008 |
| First posted | Feb 10, 2006 |
| Last update posted | Nov 24, 2011 |
| Countries | Canada |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: